In accordance with public notice requirements established at 42 CFR 430.20 and 42 CFR 447.205, the Indiana Family and Social Services Administration (FSSA), Office of Medicaid Policy and Planning (OMPP) publishes this notice of proposed changes to the Indiana Health Coverage Programs prescription drug benefit preferred drug list (PDL) and subsequent supplemental rebate collections. The public notice period will run 03/15/2023 to 04/14/2023.

FSSA-OMPP proposes that managed care entities contracted with the state of Indiana follow a statewide uniform preferred drug list (SUPDL) for drugs listed in the classes on the fee-for-service (FFS) PDL. Following SUPDL, the state will amend its supplemental rebate agreements with drug manufacturers so that the state may collect supplemental rebates for utilization from both FFS and managed care outpatient drug claims. These changes will be effective July 5, 2023.

A copy of this notice is now on file at the Indiana Government Center South, 402 West Washington Street, Room W451, Indianapolis, Indiana and is open for public inspection. Also, a copy of this notice is now available and may be inspected by contacting the local county Division of Family Resources office, except in Marion County, where public inspection may be made at 402 West Washington Street, Room W374, Indianapolis, Indiana.

There will be no public hearing. Written comments may be directed to FSSA, Office of Medicaid Policy and Planning, Attention: Madison May-Gruthusen, 402 West Washington Street, Room W382, P.O. Box 7083, Indianapolis, IN 46207-7083 or by email to spacomment@fssa.in.gov. Correspondence should be identified in the following manner: COMMENT RE: SINGLE UNIFORM PREFERRED DRUG LIST. Written comments will be made available for public inspection at the address herein of the OMPP.

Daniel Rusyniak, MD

Secretary

Family and Social Services Administration